The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma |
| |
Authors: | Baker Amanda F Dragovich Tomislav Tate Wendy R Ramanathan Ramesh K Roe Denise Hsu Chiu-Hsieh Kirkpatrick D Lynn Powis Garth |
| |
Institution: | Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA. |
| |
Abstract: | Thioredoxin-1 (Trx-1) is a small redox protein that is overexpressed in many human tumors, where it is associated with aggressive tumor growth and decreased patient survival. Trx-1 is secreted by tumor cells and is present at increased levels in the plasma of cancer patients. PX-12 is an irreversible inhibitor of Trx-1 currently in clinical development as an antitumor agent. We have used SELDI-TOF mass spectroscopy to measure plasma Trx-1 from patients treated with PX-12 during a phase I study. Mean plasma Trx-1 levels at pretreatment were significantly elevated in the cancer patients at 182.0 ng/mL compared with 27.1 ng/mL in plasma from healthy volunteers. PX-12 treatment significantly lowered plasma Trx-1 in cancer patients having the highest plasma Trx-1 pretreatment levels. High-plasma vascular endothelial growth factor (VEGF) levels have been correlated to decreased patient survival. PX-12 treatment also significantly lowered plasma VEGF levels in cancer patients with high pretreatment VEGF levels. SELDI-TOF mass spectrometry identified seven additional plasma proteins whose levels decreased after PX-12 administration, one of which was identified as a truncated form of transthyretin. The results of this study suggest that the lowering of elevated levels of plasma Trx-1 in cancer patients may provide a surrogate for the inhibition of tumor Trx-1 by PX-12. Furthermore, PX-12 decreases plasma VEGF levels that may contribute to the antitumor activity of PX-12. |
| |
Keywords: | Cys cysteine NADHP nicotine adenine dinucleotide phosphate PX-12 1-methylpropyl 2-imidazolyl disulfide SELDI-TOF-MS surface enhanced laser desorption/ionization time-of-flight mass spectroscopy Trx-1 thioredoxin-1 VEGF vascular endothelial growth factor |
本文献已被 ScienceDirect PubMed 等数据库收录! |